Evaluating Human Papillomavirus Vaccination Programs
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated vaccination programs with a vaccine against HPV-16 and HPV-18. We developed disease transmission models that estimated...
Main Authors: | Al V. Taira, Christopher P. Neukermans, Gillian D. Sanders |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2004-11-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/10/11/04-0222_article |
Similar Items
-
Preventive vaccines for cervical cancer Vacunas para prevenir el cáncer cervical
by: COSETTE M WHEELER
Published: (1997-07-01) -
The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children
by: Erika Biederman, et al.
Published: (2021-04-01) -
High-Risk Human Papillomavirus and Tobacco Smoke Interactions in Epithelial Carcinogenesis
by: Francisco Aguayo, et al.
Published: (2020-08-01) -
State statutes and regulations related to human papillomavirus vaccination
by: Aila Hoss, et al.
Published: (2019-08-01) -
Efficacy of Human Papillomavirus Vaccines for Recalcitrant Anogenital and Oral Warts
by: Giulia Ciccarese, et al.
Published: (2023-11-01)